Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 9.691% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) Cc1ccc(-c2ccc(SCC(=O)NC3CCCCC3)nn2)cc1
b.) CC(C)(C)OC(=O)N[C@@H](COCc1ccccc1)C(=O)N[C@@H](CO)[C@H](O)[C@@H]1C[C@@H]1C(=O)N1CCCC1
Answer: a. Cc1ccc(-c2ccc(SCC(=O)NC3CCCCC3)nn2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2ccc(SCC(=O)NC3CCCCC3)nn2)cc1
Cc1ccc(-c2ccc(SCC(=O)NC3CCCCC3)nn2)cc1
N-cyclohexyl-2-[6-(4-methylphenyl)pyridazin-3-yl]sulfanylacetamide